|
Real-time Estimate
Cboe BZX
-
02:29 2022-06-27 pm EDT
|
96.79 |
USD
|
|
-0.20%
|
|
|
|
06/15 | INSIDER SELL : Edwards Lifesciences | MT |
06/09 | Corvia Medical, Inc. announced that it has received $54 million in funding from Accelmed Partners, Lumira Ventures, General Catalyst Group Management, LLC, Third Rock Ventures, LLC, Edwards Lifesciences Corporation, and other investors | CI |
06/09 | Corvia Medical, Inc. announced that it has received $54 million funding from General Catalyst Group Management, LLC, Edwards Lifesciences Corporation, Lumira Ventures, Third Rock Ventures, LLC, Accelmed Partners | CI |
|
|
|
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- hemodynamic monitoring systems (67%);
- heart valves and surgery products (17%);
- other (16%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (56.6%), Europe (22.8%), Japan (10.1%) and other (10.5%).
Number of employees : 15 700 people.
|
|
| 2020 | 2021 | Delta | Transcatheter Aortic Valve Replacement | 2 857.30 | 65.1% | 3 422.50 | 65.4% | +19.78% |
Surgical Structural Heart | 761.80 | 17.4% | 889.10 | 17% | +16.71% |
Critical Care | 725.40 | 16.5% | 834.90 | 16% | +15.1% |
Transcatheter Mitral and Tricuspid Therapies | 41.80 | 1% | 86.00 | 1.6% | +105.74% |
USD in Million |
|
|
| 2020 | 2021 | Delta | United States | 2 516.80 | 57.4% | 2 963.10 | 56.6% | +17.73% |
Europe | 973.60 | 22.2% | 1 190.30 | 22.7% | +22.26% |
Rest of World | 435.80 | 9.9% | 550.20 | 10.5% | +26.25% |
Japan | 460.10 | 10.5% | 528.90 | 10.1% | +14.95% |
USD in Million |
|
|
| Vote  | Quantity | Free-Float | Company-owned shares | Total Float |
Stock A |
1 |
643,251,736 |
616,879,056 |
95.9% |
21,500,000 |
3.3% |
95.9% |
|
|
Name | Equities | % | The Vanguard Group, Inc. | 47,203,207 |
7.59% | Capital Research & Management Co. (World Investors) | 32,636,400 |
5.25% | Shapiro Capital Management LLC | 27,086,820 |
4.36% | SSgA Funds Management, Inc. | 26,921,786 |
4.33% | Capital Research & Management Co. (International Investors) | 22,150,133 |
3.56% | Walter Scott & Partners Ltd. | 15,799,469 |
2.54% | Iridian Asset Management LLC | 15,665,532 |
2.52% | Wellington Management Co. LLP | 14,993,523 |
2.41% | AllianceBernstein LP | 14,078,541 |
2.26% | BlackRock Fund Advisors | 13,660,641 |
2.20% |
|
Company contact information |
|
Edwards Lifesciences Corporation 1 Way Edwards CA 92614 Irvine, California Phone : +1 949 250 2500 Fax : +1 949 250 2525 web site : https://www.edwards.com/
|
|
|
Sector Other Advanced Medical Equipment & Technology
Connections : Edwards Lifesciences Corporation
|
|
|
|